ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
ConditionAnal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorUniversity of Minnesota
About this trial
The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
≥18 years of age
Current resident of the U.S.
Engage in anoreceptive intercourse with male partners
Fluent in English or Spanish
Disqualifiers
Under the age of 18 years old
Not living in the United States
Not born with sex assigned at birth as male
Does not engage in sex with male partners
Trial population
MSM population, which may include individuals who may identify as having a sexual orientation of gay, bisexual, or gender-queer. They may identify as any gender, including trans-gender or non-binary (but limited to those born with sex assigned at birth as male).
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Observational/Survery
Other interventionMSM participants will complete a one-time survey, delivered in an e-format. Survey will be accessible via Meta-based social media platforms (Facebook, Instagram).
Treatment groups
5,000 Participants
are divided into 1 treatment groupGroup A: Men who have sex with men (MSM)1 intervention
Trial outcomes
Primary outcomes
1
MSM awareness of anal cancer risk
Survey with question items on participants' awareness of anal cancer risk
Time frame
2 months2
MSM awareness of strategies to decrease anal cancer risk
Survey with question items of strategies to decrease anal cancer risk
Time frame
2 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov